Novel biomarker has potential for predicting and treating skin cancer metastasis

Published Date: 30 May 2025

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous squamous cell carcinoma (cSCC), the most common type of metastatic skin cancer.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions

2.

Chris Hoy reveals that he has terminal cancer?here's how to spot early signs of prostate cancer

3.

Frontline EGFR/VEGF Inhibition Slows Advanced EGFR-Positive Lung Cancer

4.

FDA Bans Red Dye No. 3 From Foods, Ingested Drugs

5.

In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot